Abstract:Stroke remains one of the main causes of mortality and morbidity worldwide. Immediately after stroke, a neuroinflammatory process starts in the brain, triggering a systemic immunodepression mainly through excessive activation of the autonomous nervous system. Manifestations of immunodepression include lymphopenia but also dysfunctional innate and adaptive immune cells. The resulting impaired antibacterial defenses render patients with stroke susceptible to infections. In addition, other risk factors like stroke severity, dysphagia, impaired consciousness, mechanical ventilation, catheterization, and older age predispose stroke patients for infections. Most common infections are pneumonia and urinary tract infection, both occur in ≈10% of the patients. Especially pneumonia increases unfavorable outcome and mortality in patients with stroke; systemic effects like hypotension, fever, delay in rehabilitation are thought to play a crucial role. Experimental and clinical data suggest that systemic infections enhance autoreactive immune responses against brain antigens and thus negatively affect outcome but convincing evidence is lacking. Prevention of poststroke infections by preventive antibiotic therapy did not improve functional outcome after stroke. Immunomodulatory approaches counteracting immunodepression to prevent stroke-associated pneumonia need to account for neuroinflammation in the ischemic brain and avoid further tissue damage. Experimental studies discovered interesting targets, but these have not yet been investigated in patients with stroke. A better understanding of the pathobiology may help to develop optimized approaches of preventive antibiotic therapy or immunomodulation to effectively prevent stroke-associated pneumonia while improving long-term outcome after stroke. In this review, we aim to characterize epidemiology, risk factors, cause, diagnosis, clinical presentation, and potential treatment of poststroke immunosuppression and associated infections.

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Systemic immune responses after ischemic stroke: From the center to the periphery

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

Immunodepression, Infections, and Functional Outcome in Ischemic Stroke.

Poststroke Lung Infection by Opportunistic Commensal Bacteria Is Not Mediated by Their Expansion in the Gut Microbiota

The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting

Potential Specific Immunological Indicators for Stroke Associated Infection Are Partly Modulated by Sympathetic Pathway Activation.

Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions

Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke

The role of β2 adrenergic receptor on infection development after ischaemic stroke

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Molecular Chaperones in Stroke-Induced Immunosuppression.

Perspective Review of Myeloid Immune Cell Responses and Poststroke Immunosuppression

Focused Update on Stroke Neuroimmunology: Current Progress in Preclinical and Clinical Research and Recent Mechanistic Insight.

Stroke-induced Immunological Alterations and Relevant Treatment Strategies

Contribution of the immune response to stroke provides promising directions for future stroke immunotherapies

Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

Cerebral ischaemic stroke results in altered mucosal IgA responses and host-commensal microbiota interactions.

Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease

New Directions in Infection-Associated Ischemic Stroke

Role of the Sympathetic Nervous System and Spleen in Experimental Stroke-Induced Immunodepression